Clinical Trial Update: Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

View source ↗

Summary

An observational clinical trial from National Taiwan University Hospital tracks changes in fibroblast growth factor 23 (FGF23) levels in patients with tumor-ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatemia
• Tumor-induced Osteomalacia

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hypophosphatemia | Status: UNKNOWN